Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College London, London, UK.
Market Access, Boehringer Ingelheim Ltd, Bracknell, UK.
Thorax. 2019 May;74(5):483-491. doi: 10.1136/thoraxjnl-2018-212514. Epub 2019 Jan 29.
Chronic respiratory diseases (CRD) are common, are increasing in prevalence, and cause significant morbidity and mortality worldwide. However, we have limited knowledge on causes of death of patients with CRD in the general population.
We evaluated mortality rates and causes of death over time in patients with CRD.
We used linked primary care and mortality data to determine mortality rates and the most common causes of death in people with CRD (including asthma, bronchiectasis, COPD and interstitial lung diseases (ILD)) during 2005-2015 in England.
We identified 558 888 patients with CRD (451 830 asthma, 137 709 COPD, 19 374 bronchiectasis, 10 745 ILD). The age-standardised mortality rate of patients with CRD was 1607 per 100 000 persons (asthma=856, COPD=1503, ILD=2609, bronchiectasis=1463). CRD mortality was overall 54% higher than the general population. A third of patients with CRD died from respiratory-related causes. Respiratory-related mortality was constant, while cardiovascular-related mortality decreased significantly over time. COPD accounted for the majority of respiratory-related deaths (66% overall) in all patient groups except ILD.
Patients with CRD continue to experience substantial morbidity and mortality due to respiratory diseases. Disease-modifying intervention strategies are needed to improve outcomes for patients with CRD.
慢性呼吸道疾病(CRD)较为常见,且其发病率在全球范围内呈上升趋势,导致了大量的发病率和死亡率。然而,我们对普通人群中 CRD 患者的死因知之甚少。
评估 CRD 患者随时间推移的死亡率和死因。
我们使用了关联的初级保健和死亡率数据,以确定在 2005 年至 2015 年期间,英格兰患有 CRD(包括哮喘、支气管扩张症、COPD 和间质性肺疾病(ILD))的患者的死亡率和最常见的死因。
我们确定了 558888 例 CRD 患者(451830 例哮喘、137709 例 COPD、19374 例支气管扩张症、10745 例 ILD)。CRD 患者的年龄标准化死亡率为每 100000 人中有 1607 人(哮喘=856,COPD=1503,ILD=2609,支气管扩张症=1463)。CRD 的总体死亡率比普通人群高出 54%。三分之一的 CRD 患者死于与呼吸相关的原因。与呼吸相关的死亡率保持不变,而心血管相关的死亡率随着时间的推移显著下降。除了 ILD 之外,在所有患者群体中,COPD 都导致了大多数与呼吸相关的死亡(总体占 66%)。
CRD 患者继续因呼吸疾病而遭受大量的发病率和死亡率。需要采取疾病修正干预策略来改善 CRD 患者的结局。